1. Home
  2. KTTA vs YHC Comparison

KTTA vs YHC Comparison

Compare KTTA & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.80

Market Cap

19.7M

Sector

Health Care

ML Signal

HOLD

Logo LQR House Inc.

YHC

LQR House Inc.

HOLD

Current Price

$1.04

Market Cap

19.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
YHC
Founded
2020
2021
Country
United States
United States
Employees
5
4
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
19.7M
19.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KTTA
YHC
Price
$0.80
$1.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
307.9K
45.2K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1,267.57
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.53
52 Week High
$2.06
$11.14

Technical Indicators

Market Signals
Indicator
KTTA
YHC
Relative Strength Index (RSI) 54.86 58.97
Support Level $0.67 $0.78
Resistance Level $0.87 $1.06
Average True Range (ATR) 0.06 0.07
MACD 0.00 0.01
Stochastic Oscillator 45.64 95.51

Price Performance

Historical Comparison
KTTA
YHC

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

Share on Social Networks: